Preclinical Trial-on-Chip Glioblastoma (GBM) Special Customization Service Powered CAR-T Development

High clinical failure rates, inaccurate blood-brain barrier (BBB) penetration data, and the limitations of animal models in replicating human tumor microenvironments are major challenges in glioblastoma (GBM) CAR-T development. Our Preclinical Trial-on-Chip Glioblastoma Special Customization Service addresses these challenges by providing high-fidelity, patient-specific microfluidic platforms that enable precise validation of therapeutic efficacy and safety. By integrating 3D bioprinting and dynamic microfluidic technology, we simulate the complex GBM landscape, streamlining CAR-T development and minimizing R&D risk for a more efficient path toward clinical success.

Introduction

GBM is a highly aggressive and treatment-resistant brain tumor, posing significant challenges for both traditional and immunotherapies. As a cutting-edge approach, the Preclinical Trial-on-Chip models mimic the tumor microenvironment (TME) of GBM, allowing researchers to test CAR-T cell efficacy in a controlled, in vitro system. Studies have shown that these models provide a more predictive platform for understanding CAR-T therapy dynamics, such as immune infiltration and tumor-targeting specificity, compared to conventional animal models.

Fig.1 A diagram depicting the GBM tumor microenvironment and the construction of a GBM-on-a-chip.¹

Service

Creative Biolabs provides a transformative solution for assessing the potency and extravasation capabilities of CAR-T cells within a human-centric system. Our specialized "GBM-on-a-chip" models offer high-resolution data on how your engineered T-cells interact with the immunosuppressive tumor microenvironment, the blood-brain barrier, and heterogeneous tumor populations.

Our service offers a customized approach to developing CAR-T therapies for glioblastoma, using innovative tumor-on-a-chip models that replicate the complexities of the human GBM tumor microenvironment. Clients can expect a highly controlled and scalable testing platform that evaluates CAR-T cell efficacy in real-time, including immune response, tumor cell interaction, and potential side effects.

Discover How We Can Help - Request a Consultation to design a chip model.

What We Can Offer

At Creative Biolabs, we provide specialized tumor-on-a-chip platforms designed to emulate the GBM microenvironment in a way that supports precise CAR-T evaluation. The platforms we use allow for the incorporation of microfluidic channels, vascularization, and immune cell infiltration, ensuring that the models reflect the complexity of GBM. Our service includes customizable models for GBM with real-time analysis of CAR-T cell action, tumor cell interactions, and cytokine profiles, offering insights into immune responses and tumor suppression.

Mainstream Technology Platforms Available:

• Microfluidic Tumor Models
• 3D Organoid Systems
• CAR-T Cell Co-Culture Platforms

These platforms enable accurate modeling and comprehensive testing of immune-oncology treatments, such as CAR-T.

Our Workflow

Required Starting Materials:

GBM cell line details: Provide the specific GBM cell lines for tumor modeling.

CAR-T construct specifications: Submit detailed information on the CAR-T design, including target antigen, scFv sequences, and co-stimulatory domain preferences.

Final Deliverables: Clients receive a Comprehensive Efficacy & Safety Report, including high-resolution microscopy images of CAR-T infiltration, extravasation efficiency data, and a Cytokine Release Profile indicating potential inflammatory responses.

Our Advantages

• Tailored Tumor-on-a-Chip Models: We design and fabricate customized microfluidic systems to replicate the GBM tumor microenvironment, including perivascular niches and oxygen gradients.
• Advanced 3D Bioprinting Capabilities: We incorporate human brain-derived ECM and co-culture GBM cells with key stromal components like astrocytes and microglia, mimicking the immunosuppressive shield of GBM.
• Functional Blood-Brain Barrier Integration: We establish a functional BBB using human brain microvascular endothelial cells to simulate realistic CAR-T cell extravasation and neurotoxicity scenarios.

FAQs

Partner with Us

Creative Biolabs provides the world's most advanced Preclinical Trial-on-Chip GBM Special Customization Service, specifically engineered to empower the next generation of CAR-T therapeutics. By bridging the gap between benchtop research and clinical reality, we help you deliver life-saving treatments to patients faster and with higher confidence. Ready to revolutionize your GBM research? Our team of scientific experts is available to design a custom platform tailored to your specific project needs. Please contact our team to discuss your project and for further information.

Reference

1. Xie, Zuorun et al. "Glioblastoma-on-a-chip construction and therapeutic applications." Frontiers in oncology vol. 13 1183059. 12 Jul. 2023. Distributed under Open Access License CC BY 4.0, without modification. https://doi.org/10.3389/fonc.2023.1183059